278 related articles for article (PubMed ID: 29326107)
1.
Srinivasan S; Kaur V; Chamarthi B; Littleton KR; Chen L; Manning AK; Merino J; Thomas MK; Hudson M; Goldfine A; Florez JC
Diabetes Care; 2018 Mar; 41(3):554-561. PubMed ID: 29326107
[TBL] [Abstract][Full Text] [Related]
2. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Li JH; Brenner LN; Kaur V; Figueroa K; Schroeder P; Huerta-Chagoya A; ; ; Udler MS; Leong A; Mercader JM; Florez JC
Diabetologia; 2023 Jul; 66(7):1260-1272. PubMed ID: 37233759
[TBL] [Abstract][Full Text] [Related]
4. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
[TBL] [Abstract][Full Text] [Related]
5. Association of GLP1R Polymorphisms With the Incretin Response.
Dorsey-Trevino EG; Kaur V; Mercader JM; Florez JC; Leong A
J Clin Endocrinol Metab; 2022 Aug; 107(9):2580-2588. PubMed ID: 35723666
[TBL] [Abstract][Full Text] [Related]
6. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.
Færch K; Pilgaard K; Knop FK; Hansen T; Pedersen O; Jørgensen T; Holst JJ
Diabetes Obes Metab; 2013 Jan; 15(1):91-5. PubMed ID: 22862926
[TBL] [Abstract][Full Text] [Related]
7. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
[TBL] [Abstract][Full Text] [Related]
8. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
9. A Reduced Incretin Effect Mediated by the rs7903146 Variant in the
Galderisi A; Tricò D; Pierpont B; Shabanova V; Samuels S; Dalla Man C; Galuppo B; Santoro N; Caprio S
Diabetes Care; 2020 Oct; 43(10):2553-2563. PubMed ID: 32788279
[TBL] [Abstract][Full Text] [Related]
10. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
Pearson ER; Donnelly LA; Kimber C; Whitley A; Doney AS; McCarthy MI; Hattersley AT; Morris AD; Palmer CN
Diabetes; 2007 Aug; 56(8):2178-82. PubMed ID: 17519421
[TBL] [Abstract][Full Text] [Related]
11. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
Schäfer SA; Tschritter O; Machicao F; Thamer C; Stefan N; Gallwitz B; Holst JJ; Dekker JM; 't Hart LM; Nijpels G; van Haeften TW; Häring HU; Fritsche A
Diabetologia; 2007 Dec; 50(12):2443-50. PubMed ID: 17661009
[TBL] [Abstract][Full Text] [Related]
12. No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect.
Mathiesen DS; Bagger JI; Hansen KB; Junker AE; Plamboeck A; Harring S; Idorn T; Hornum M; Holst JJ; Jonsson AE; Hansen T; Vilsbøll T; Lund A; Knop FK
Endocr Connect; 2020 Dec; 9(12):1221-1232. PubMed ID: 33252353
[TBL] [Abstract][Full Text] [Related]
13. Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant.
Daniele G; Gaggini M; Comassi M; Bianchi C; Basta G; Dardano A; Miccoli R; Mari A; Gastaldelli A; Del Prato S
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1160-7. PubMed ID: 26046964
[TBL] [Abstract][Full Text] [Related]
14. Glucose tolerance and free fatty acid metabolism in adults with variations in TCF7L2 rs7903146.
Lu J; Varghese RT; Zhou L; Vella A; Jensen MD
Metabolism; 2017 Mar; 68():55-63. PubMed ID: 28183453
[TBL] [Abstract][Full Text] [Related]
15. Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.
Heni M; Ketterer C; Thamer C; Herzberg-Schäfer SA; Guthoff M; Stefan N; Machicao F; Staiger H; Fritsche A; Häring HU
Diabetes; 2010 Dec; 59(12):3247-52. PubMed ID: 20802253
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics.
Dhawan D; Padh H
Diabetes Res Clin Pract; 2016 Nov; 121():35-40. PubMed ID: 27639123
[TBL] [Abstract][Full Text] [Related]
17. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
18. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women.
Reyes-López R; Pérez-Luque E; Malacara JM
Diabetes Metab Res Rev; 2014 Nov; 30(8):701-6. PubMed ID: 24639413
[TBL] [Abstract][Full Text] [Related]
19. Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity.
Boccardi V; Ambrosino I; Papa M; Fiore D; Rizzo MR; Paolisso G; Barbieri M
Eur J Hum Genet; 2010 Dec; 18(12):1333-8. PubMed ID: 20648057
[TBL] [Abstract][Full Text] [Related]
20. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
